NRX Pharmaceuticals (NRXP) Current Assets (2017 - 2026)
NRX Pharmaceuticals (NRXP) posted quarterly Current Assets of $7.4 million for Q1 2026, up 1.45% year-over-year from $7.3 million in Q1 2025, and down 17.22% quarter-over-quarter from $8.9 million in Q4 2025.
NRX Pharmaceuticals (NRXP) Current Assets (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Current Assets for 10 consecutive years, with $7.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 1.45% year-over-year to $7.4 million; the TTM figure through Mar 2026 stood at $7.4 million (up 1.45% YoY), while the FY2025 annual figure was $8.9 million, up 169.29% from the prior year.
- Current Assets eased to $7.4 million in Q1 2026 per NRXP's latest filing, from $8.9 million in the prior quarter.
- Across five years, Current Assets topped out at $43.6 million in Q1 2022 and bottomed at $3.3 million in Q4 2024.
- Historically, Current Assets has averaged $14.3 million across 5 years, with a median of $8.9 million in 2025.
- Annual changes were most pronounced in 2022 — Current Assets jumped 72875.69% — and 2024, when it slumped 84.62%.
- NRX Pharmaceuticals' Current Assets stood at $25.8 million in 2022, then plunged by 73.31% to $6.9 million in 2023, then sank by 52.03% to $3.3 million in 2024, then jumped by 169.29% to $8.9 million in 2025, then dropped by 17.22% to $7.4 million in 2026.
- Business Quant data shows NRXP's Current Assets at $7.4 million in Q1 2026, $8.9 million in Q4 2025, and $11.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 1.76 Bn |
| 10 | NRX Pharmaceuticals | 130.83 Mn | 104.13 Mn | 426,000.00 | 29.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.36 Mn |
| Dec 31, 2025 | 8.89 Mn |
| Sep 30, 2025 | 11.95 Mn |
| Jun 30, 2025 | 4.59 Mn |
| Mar 31, 2025 | 7.26 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 4.88 Mn |
| Mar 31, 2024 | 3.35 Mn |
| Dec 31, 2023 | 6.88 Mn |
| Sep 30, 2023 | 13.09 Mn |
| Jun 30, 2023 | 19.79 Mn |
| Mar 31, 2023 | 21.76 Mn |
| Dec 31, 2022 | 25.80 Mn |
| Sep 30, 2022 | 24.80 Mn |
| Jun 30, 2022 | 32.41 Mn |
| Mar 31, 2022 | 43.58 Mn |
| Dec 31, 2021 | 32.71 Mn |
| Sep 30, 2021 | 45.23 Mn |
| Jun 30, 2021 | 18.53 Mn |